Follicular Lymphoma

Common Name(s)

Follicular Lymphoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Follicular Lymphoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Follicular Lymphoma" returned 643 free, full-text research articles on human participants. First 3 results:

Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma.
 

Author(s): Ellen Berget, Lars Helgeland, Knut Liseth, Turid Løkeland, Anders Molven, Olav Karsten Vintermyr

Journal: J. Clin. Pathol.. 2014 Dec;67(12):1072-7.

 

We aimed to evaluate the prognostic value of routine use of PCR amplification of immunoglobulin gene rearrangements in bone marrow (BM) staging in patients with follicular lymphoma (FL).

Last Updated: 15 Nov 2014

Go To URL
A case of t(14; 18)-negative follicular lymphoma with atypical immunophenotype: usefulness of immunoarchitecture of Ki67, CD79a and follicular dendritic cell meshwork in making the diagnosis.
 

Author(s): Yin- Ping Wong, Faridah Abdul-Rahman, Aamad Toha Samsudin, Noraidah Masir

Journal: Malays J Pathol. 2014 Aug;36(2):125-9.

 

Follicular lymphoma is characterised by the t(14;18)(q32;q21) chromosomal translocation causing BCL2 protein overexpression. A proportion of follicular lymphomas do not carry the t(14;18) translocation and lacked BCL2 protein expression. We describe a case of a BCL2 protein- and t(14;18)-negative ...

Last Updated: 8 Sep 2014

Go To URL
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy.
 

Author(s): Elisa Oricchio, Giovanni Ciriello, Man Jiang, Michael H Boice, Jonathan H Schatz, Adriana Heguy, Agnes Viale, Elisa de Stanchina, Julie Teruya-Feldstein, Alyssa Bouska, Tim McKeithan, Chris Sander, Wayne Tam, Venkatraman E Seshan, Wing-Chung Chan, R S K Chaganti, Hans-Guido Wendel

Journal: J. Exp. Med.. 2014 Jun;211(7):1379-91.

 

Loss of cell cycle controls is a hallmark of cancer and has a well-established role in aggressive B cell malignancies. However, the role of such lesions in indolent follicular lymphoma (FL) is unclear and individual lesions have been observed with low frequency. By analyzing genomic ...

Last Updated: 1 Jul 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Follicular Lymphoma" returned 66 free, full-text review articles on human participants. First 3 results:

Hematopoietic stem cell transplantation for follicular lymphoma: optimal timing and indication.
 

Author(s): Sung Won Kim

Journal: J Clin Exp Hematop. 2014 ;54(1):39-47.

 

The definitive management of advanced follicular lymphoma (FL) remains controversial due to various treatment options, including watchful waiting, single-agent or combination chemotherapy, monoclonal antibody, and radioimmunotherapy. These options can provide prolonged progression-free ...

Last Updated: 19 Jun 2014

Go To URL
Treatment of follicular lymphoma.
 

Author(s): Koji Izutsu

Journal: J Clin Exp Hematop. 2014 ;54(1):31-7.

 

Follicular lymphoma (FL) is the most common subtype of indolent lymphomas. Several lines of evidence suggest that the prognosis of patients with FL has improved since the introduction of rituximab, although cure cannot be achieved. Although the treatment paradigm for FL has changed ...

Last Updated: 19 Jun 2014

Go To URL
Molecular pathogenesis of follicular lymphoma.
 

Author(s): Wataru Kishimoto, Momoko Nishikori

Journal: J Clin Exp Hematop. 2014 ;54(1):23-30.

 

t(14;18) translocation has been recognized as a genetic hallmark of follicular lymphoma (FL), but it is now known that additional genetic aberrations are required for the development of FL. With recent advances in the technology for DNA analysis, recurrent gene aberrations such as ...

Last Updated: 19 Jun 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
 

Status: Recruiting

Condition Summary: Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage II Grade 1 Contiguous Follicular Lymphoma; Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Stage II Grade 2 Contiguous Follicular Lymphoma; Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma

 

Last Updated: 20 Feb 2015

Go to URL
Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
 

Status: Recruiting

Condition Summary: Follicular Lymphoma; Follicular Non-Hodgkin´s Lymphoma; Autologous Effector Lymphocytes

 

Last Updated: 5 Aug 2013

Go to URL
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
 

Status: Recruiting

Condition Summary: Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage II Grade 1 Contiguous Follicular Lymphoma; Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Stage II Grade 2 Contiguous Follicular Lymphoma; Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Stage II Grade 3 Contiguous Follicular Lymphoma; Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma

 

Last Updated: 23 Feb 2015

Go to URL